FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247592462> ?p ?o ?g. }

• W4247592462 endingPage "102" @default.
• W4247592462 startingPage "96" @default.
• W4247592462 abstract "Objective: Our objective was to study the direct action of the gonadotropin-releasing hormone antagonist SB-75 and the agonist buserelin on the proliferation of endometrial cancer cells. Study Design: Two human endometrial cell lines that differ in histologic subtype and estrogen receptor content were treated with gonadotropin-releasing hormone analog. We measured the number of viable cells, cell cycle parameters, and apoptotic processes. Results: Growth of the Ishikawa cells was inhibited by SB-75 in a dose-dependent manner. 17β-Estradiol partially abolished the inhibitory effect of SB-75. The growth of the HEC-1A cells was not affected by the antagonist. Neither endometrial cancer cell line showed significant sensitivity to the agonist buserelin. Tenfold concentration of the gonadotropin-releasing hormone agonist did not abolish the inhibitory effect of the antagonist on cell growth. The growth inhibition was not associated with any change in cell cycle parameters but was associated with an induction of apoptosis. Conclusion: The gonadotropin-releasing hormone antagonist SB-75 directly inhibits the growth of some human endometrial cancer cells and thus may be suitable for the treatment of endometrial tumors. Objective: Our objective was to study the direct action of the gonadotropin-releasing hormone antagonist SB-75 and the agonist buserelin on the proliferation of endometrial cancer cells. Study Design: Two human endometrial cell lines that differ in histologic subtype and estrogen receptor content were treated with gonadotropin-releasing hormone analog. We measured the number of viable cells, cell cycle parameters, and apoptotic processes. Results: Growth of the Ishikawa cells was inhibited by SB-75 in a dose-dependent manner. 17β-Estradiol partially abolished the inhibitory effect of SB-75. The growth of the HEC-1A cells was not affected by the antagonist. Neither endometrial cancer cell line showed significant sensitivity to the agonist buserelin. Tenfold concentration of the gonadotropin-releasing hormone agonist did not abolish the inhibitory effect of the antagonist on cell growth. The growth inhibition was not associated with any change in cell cycle parameters but was associated with an induction of apoptosis. Conclusion: The gonadotropin-releasing hormone antagonist SB-75 directly inhibits the growth of some human endometrial cancer cells and thus may be suitable for the treatment of endometrial tumors." @default.
• W4247592462 created "2022-05-12" @default.
• W4247592462 creator A5002344304 @default.
• W4247592462 creator A5002797484 @default.
• W4247592462 creator A5040234663 @default.
• W4247592462 creator A5063527404 @default.
• W4247592462 creator A5068739269 @default.
• W4247592462 date "1994-01-01" @default.
• W4247592462 modified "2023-09-25" @default.
• W4247592462 title "Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: Role of apoptosis" @default.
• W4247592462 cites W1485476587 @default.
• W4247592462 cites W1795675730 @default.
• W4247592462 cites W1972020194 @default.
• W4247592462 cites W1994780917 @default.
• W4247592462 cites W2011695495 @default.
• W4247592462 cites W2016514222 @default.
• W4247592462 cites W2022690114 @default.
• W4247592462 cites W2026829967 @default.
• W4247592462 cites W2033312402 @default.
• W4247592462 cites W2035104564 @default.
• W4247592462 cites W2040974167 @default.
• W4247592462 cites W2042297156 @default.
• W4247592462 cites W2047325423 @default.
• W4247592462 cites W2049941029 @default.
• W4247592462 cites W2058342890 @default.
• W4247592462 cites W2075910829 @default.
• W4247592462 cites W2132602939 @default.
• W4247592462 cites W2065662573 @default.
• W4247592462 doi "https://doi.org/10.1016/s0002-9378(13)70287-4" @default.
• W4247592462 hasPublicationYear "1994" @default.
• W4247592462 type Work @default.
• W4247592462 citedByCount "3" @default.
• W4247592462 countsByYear W42475924622015 @default.
• W4247592462 countsByYear W42475924622017 @default.
• W4247592462 crossrefType "journal-article" @default.
• W4247592462 hasAuthorship W4247592462A5002344304 @default.
• W4247592462 hasAuthorship W4247592462A5002797484 @default.
• W4247592462 hasAuthorship W4247592462A5040234663 @default.
• W4247592462 hasAuthorship W4247592462A5063527404 @default.
• W4247592462 hasAuthorship W4247592462A5068739269 @default.
• W4247592462 hasConcept C121608353 @default.
• W4247592462 hasConcept C126322002 @default.
• W4247592462 hasConcept C134018914 @default.
• W4247592462 hasConcept C170493617 @default.
• W4247592462 hasConcept C190283241 @default.
• W4247592462 hasConcept C2776363309 @default.
• W4247592462 hasConcept C2776885963 @default.
• W4247592462 hasConcept C2777088508 @default.
• W4247592462 hasConcept C2777164284 @default.
• W4247592462 hasConcept C2777230143 @default.
• W4247592462 hasConcept C2778575703 @default.
• W4247592462 hasConcept C2778782382 @default.
• W4247592462 hasConcept C2778894405 @default.
• W4247592462 hasConcept C2778938600 @default.
• W4247592462 hasConcept C2779045069 @default.
• W4247592462 hasConcept C2779192864 @default.
• W4247592462 hasConcept C530470458 @default.
• W4247592462 hasConcept C54355233 @default.
• W4247592462 hasConcept C55493867 @default.
• W4247592462 hasConcept C62112901 @default.
• W4247592462 hasConcept C71315377 @default.
• W4247592462 hasConcept C71924100 @default.
• W4247592462 hasConcept C84606932 @default.
• W4247592462 hasConcept C86803240 @default.
• W4247592462 hasConcept C96232424 @default.
• W4247592462 hasConceptScore W4247592462C121608353 @default.
• W4247592462 hasConceptScore W4247592462C126322002 @default.
• W4247592462 hasConceptScore W4247592462C134018914 @default.
• W4247592462 hasConceptScore W4247592462C170493617 @default.
• W4247592462 hasConceptScore W4247592462C190283241 @default.
• W4247592462 hasConceptScore W4247592462C2776363309 @default.
• W4247592462 hasConceptScore W4247592462C2776885963 @default.
• W4247592462 hasConceptScore W4247592462C2777088508 @default.
• W4247592462 hasConceptScore W4247592462C2777164284 @default.
• W4247592462 hasConceptScore W4247592462C2777230143 @default.
• W4247592462 hasConceptScore W4247592462C2778575703 @default.
• W4247592462 hasConceptScore W4247592462C2778782382 @default.
• W4247592462 hasConceptScore W4247592462C2778894405 @default.
• W4247592462 hasConceptScore W4247592462C2778938600 @default.
• W4247592462 hasConceptScore W4247592462C2779045069 @default.
• W4247592462 hasConceptScore W4247592462C2779192864 @default.
• W4247592462 hasConceptScore W4247592462C530470458 @default.
• W4247592462 hasConceptScore W4247592462C54355233 @default.
• W4247592462 hasConceptScore W4247592462C55493867 @default.
• W4247592462 hasConceptScore W4247592462C62112901 @default.
• W4247592462 hasConceptScore W4247592462C71315377 @default.
• W4247592462 hasConceptScore W4247592462C71924100 @default.
• W4247592462 hasConceptScore W4247592462C84606932 @default.
• W4247592462 hasConceptScore W4247592462C86803240 @default.
• W4247592462 hasConceptScore W4247592462C96232424 @default.
• W4247592462 hasIssue "1" @default.
• W4247592462 hasLocation W42475924621 @default.
• W4247592462 hasOpenAccess W4247592462 @default.
• W4247592462 hasPrimaryLocation W42475924621 @default.
• W4247592462 hasRelatedWork W1970749368 @default.
• W4247592462 hasRelatedWork W2014130374 @default.
• W4247592462 hasRelatedWork W2019080786 @default.
• W4247592462 hasRelatedWork W2021202189 @default.

• next